This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

aTyr Pharma Inc (LIFE)

: Health Care

Company Balance Sheet
Dec 2015 Dec 2014
Cash and Equivalents 53.02M 13.90M
Receivables 0.00 0.00
Inventories 0.00 0.00
Other Current Assets 0.00 0.00
Total Current Assets 97.95M 16.51M
Property, Plant & Equipment, Gross 5.54M 4.89M
Accumulated Depreciation & Depletion 3.75M 2.96M
Property, Plant & Equipment, Net 1.79M 1.93M
Intangibles 0.00 0.00
Other Non-Current Assets 29.93M 2.21M
Total Non-Current Assets 31.73M 4.13M
Liabilities & Shareholder Equity
Total Assets 129.68M 20.64M
Accounts Payable 3.87M 1.43M
Short Term Debt 3.37M 5.13M
Other Current Liabilities 0.00 0.00
Total Current Liabilities 12.15M 9.79M
Long Term Debt 1.78M 5.14M
Deferred Income Taxes 130.00K 445.00K
Other Non-Current Liabilities 571.00K 335.00K
Minority Interest 0.00 0.00
Total Non-Current Liabilities 2.48M 5.92M
Total Liabilities 14.62M 15.72M
Preferred Stock Equity 0.00 0.00
Common Stock Equity 115.05M 4.93M
Common Par 24.00K 10.00K
Additional Paid In Capital 273.32M 115.14M
Cumulative Translation Adjustment 0.00 0.00
Retained Earnings -158.12M -110.15M
Treasury Stock 0.00 0.00
Other Equity Adjustments -171.00K -69.00K
Total Capitalization 116.83M 10.07M
Total Equity 115.05M 4.93M
Total Liabilities & Stock Equity 129.68M 20.64M
Total Common Shares Outstanding 23.67M 22.55M
Preferred Shares 0.00 0.00
Treasury Shares 0.00 0.00
Basic Weighted Shares Outstanding 15.84M 10.07M
Diluted Weighted Shares Outstanding 15.84M 10.07M
Number of Employees 55 NA
Number of Part-Time Employees 0 NA

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

LIFE aTyr Pharma Inc

Chart of LIFE

Analysts Ratings for LIFE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 2 2 2
Moderate Buy 0 0 0 0
Hold 2 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

LIFE Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs